Sometimes the major annual medical meetings are jam-packed with significant and market-moving data. And then sometimes they’re like this year’s American College of Cardiology conference, with relatively limited useful data from an investing perspective.
Blog
U.K. regulator opens new “office” for innovative medical devices
By Stewart Eisenhart, Emergo Group
The Medicines and Healthcare Products Regulatory Agency (MHRA), the UK medical device market regulator, has set up an "innovation office" in an effort to provide a more efficient market authorization process for manufacturers of cutting-edge products.
New U.S. FDA guidance on financial disclosure requirements for clinical investigators
By Stewart Eisenhart, Emergo Group
New guidance from the US Food and Drug Administration revises financial disclosure requirements made by medical device clinical study sponsors to clinical investigators.
Covidien Ventures’ Amy Belt discusses the origins of Medtech Women
This article is an excerpt from a blog post originally published on biodesignalumni.com
Why do women rarely headline medtech conferences?
Amy Belt, Director, Covidien Ventures, pondered this question in the spring of 2009, looking out to a sea of navy blue blazers and calculating only 4% of the podium speakers at her 3 > previous conferences were women.
When EMR companies muzzle doctors
‘Burn the data’: Did a company try to hide risks of MRI dye Omniscan?
by Jeff Gerth, ProPublica
In 1994, a scientist studying her company’s new medical imaging dye reached troubling findings. Her boss, she recalls, told her to “burn the data.”
The PREVAIL flail: A contrarian view
"The good thing about bad news – it sells."
Why Grey’s Anatomy is a bad place to promote device research
For medical students, residents, and attendings aspiring to develop a new medical device that is FDA approved for patient use, there are a few things you should remember:
How materials testing meets international regulations for the medical device market
European lawmakers are considering new regulations for managing the development of medical devices and implants. This is due to the after-affects of several defective devices hitting the market. Materials testing is one important step for ensuring the safety of all heart stents, bone screws and other biomaterials. ADMET offers a multitude of testing machines for the biomedical market. Read more.